Successful coordination and execution of nontherapeutic studies in a cooperative group setting: Lessons learned from children's oncology group studies

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 7, 2008, Pages 1665-1673

  Carter, Andrea ^a   Landier, Wendy ^a   Schad, Amy ^a   Moser, Allison ^a   Schaible, Alexandra ^a   Hanby, Cara ^a   Kurian, Seira ^a   Wong, F Lennie ^a   Villaluna, Doojduen ^a   Bhatia, Smita ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER RESEARCH; CANCER RISK; CANCER SURVIVAL; CHILDHOOD CANCER; CONTROLLED STUDY; HEALTH CENTER; HEALTH SERVICE; HUMAN; INFORMATION PROCESSING; PATIENT PARTICIPATION; PRIORITY JOURNAL; QUALITY CONTROL; QUESTIONNAIRE; SCHOOL CHILD;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CLINICAL TRIALS AS TOPIC; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; NEOPLASMS; QUALITY CONTROL; RESEARCH SUPPORT AS TOPIC; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 53549120644     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2862     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Ross JA, Severson RK, Pollock BH, Robison LL. Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer 1996;77:201-7.
3. Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996;334:745-51.
4. Bhatia S, Sather HN, Pabustan OB, Trigg ME, Gaynon PS, Robison LL. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 2002;99:4257-64.
5. Bokemeyer C, Schmoll HJ, van Rhee J, Kuczyk M, Schuppert F, Poliwoda H. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma. Ann Hematol 1994;68:105-10.
6. Christie D, Leiper AD, Chessells JM, Vargha-Khadem F. Intellectual performance after presymptomatic cranial radiotherapy for leukaemia: effects of age and sex. Arch Dis Child 1995;73:136-40.
7. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991;325:599-605.
8. Haupt R, Fears TR, Robison LL, et al. Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. JAMA 1994;272:1427-32.
9. Kremer LC, van Dalen EC, Offringa M, Voute PA. Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Ann Oncol 2002;13:503-12.
10. Kremer LC, van Dalen EC, Offringa M, Ottenkamp J, Voute PA. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol 2001;19:191-6.
11. Mattano LA, Jr., Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol 2000;18:3262-72.
12. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 2001;93:618-29.
13. Mertens AC, Yasui Y, Liu Y, et al. Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study. Cancer 2002;95:2431-41.
14. Gurney JG, Kadan-Lottick NS, Packer RJ, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 2003;97:663-73.
15. Sklar CA, Mertens AC, Mitby P, et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2002;87:3136-41.
16. Green D, Zevon M, Rock K. Fatigue after treatment for Hodgkin's disease during childhood or adolescence. Proc Am Soc Clin Oncol 2002;21.
17. Hogeboom CJ, Grosser SC, Guthrie KA, Thomas PR, D'Angio GJ, Breslow NE. Stature loss following treatment for Wilms' tumor. Med Pediatr Oncol 2001;36:295-304.
18. Green DM, Grigoriev YA, Nan B, et al. Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group. J Clin Oncol 2001;19:1926-34.
19. Breslow NE, Takashima JR, Whitton JA, Moksness J, D'Angio GJ, Green DM. Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 1995;13:1851-9.
20. Bhatia S, Sather HN, Heerema NA, Trigg ME, Gaynon PS, Robison LL. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 2002;100:1957-64.
21. Kadan-Lottick NS, Ness KK, Bhatia S, Gurney JG. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA 2003;290:2008-14.
22. Caloto T. Quality control and data-handling in multicentre studies: the case of the Multicentre Project for Tuberculosis Research. BMC Med Res Methodol 2001;1:14.
23. Weiss RB. Systems of protocol review, quality assurance, and data audit. Cancer Chemother Pharmacol 1998;Suppl 42:S88-92.
24. Blumenstein BA, James KE, Lind BK, Mitchel HE. Functions and organization of coordinating centres for multicenter studies. Controlled Clin Trials 1995;16:4-29S.
25. Gassman JJ, Owen WW, Kuntz TE, Martin JP, Amoroso WP. Data quality assurance, monitoring, and reporting. Control Clin Trials 1995;16:104-36S.
26. Wolter JM. Quality assurance in a cooperative group. Cancer Treat Rep 1985;69:1189-93.
27. Cassel GH, Ferris FL III. Site visits in a multicenter ophthalmic clinical trial. Control Clin Trials 1984;5:251-62.